NEW ORLEANS — Long-term pain reduction with combined occipital and supraorbital nerve stimulation for chronic migraine does not imply improved long-term functional outcome, a new study shows.

The device acts on the supraorbital nerve and supratrochlear nerve, the nerves that transmit migraine pain. The Food and Drug Administration (FDA) has cleared WAT Medical’s HeadaTerm 2 as an ...

And nerve stimulation devices (transcutaneous supraorbital nerve stimulation, external vagal nerve stimulation and distal transcutaneous electrical stimulation) can be helpful. Also, keep a headache ...

Highlighting the latest migraine-related news reported across MJH Life Sciences™. But those who suffer from the condition may be labeled as attention-seeking or have their attacks downplayed as just a ...